Validation of RetmarkerAMD as a semiautomatic grading software for AMD – (Eye Journal)
Eye, Published online: 23 October 2019; doi:10.1038/s41433-019-0624-7 Validation of RetmarkerAMD as a semiautomatic grading software for AMD
Safety Alert – Allergan’s Xen 45 glaucoma surgical drainage device
Allergan has contacted the RCOphth to provide a follow up regarding the hold on XEN 45. Allergan has reached out to regulatory agencies, and is working to initiate a voluntary recall of affected lots of XEN 45. During an inspection process a small number of units in an unreleased XEN 45 lot were observed to have trace
Ophthalmic biosimilars and biologics—role of endotoxins – (Eye Journal)
Eye, Published online: 16 October 2019; doi:10.1038/s41433-019-0636-3 Ophthalmic biosimilars and biologics—role of endotoxins
Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema – (Eye Journal)
Eye, Published online: 16 October 2019; doi:10.1038/s41433-019-0615-8 Translating evidence into practice: recommendations by a UK expert panel on the use of aflibercept in diabetic macular oedema
Vision UK announce winners of their new awards
The RCOphth is delighted to share the news that Jugnoo Rahi, RCOphth Academic Chair and Lola Solebo won awards alongside a high quality line up of nominations at the Vision UK Forward View Eye Health and Sight Loss Conference held in collaboration with the Royal Society of Medicine (RSM) in October 2019. Jugnoo was the winner